Anti-CD20 Therapies in Pediatric Acquired Demyelinating Syndromes: Evidence Across MS, AQP4-IgG-Positive NMOSD and MOGAD. Margoni M, Preziosa P, Rocca MA, Filippi M CNS Drugs. 2026 Jun 23. PMID: 42334795. Abstract CommentRecommendBookmarkWatch
